We are live on
!
Find out more
OIM
Oracle Investment Management Portfolio holdings
AUM
$168M
1-Year Est. Return
42.86%
This Fund
S&P 500
This Quarter
Est. Return
+14.3%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$136M
AUM Growth
+$32.4M
(+31%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
17.55%
Top 10 Holdings %
Top 10 Hldgs %
79.4%
Holding
37
New
10
Increased
5
Reduced
9
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QuidelOrtho
QDEL
|
+$4.33M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$2.25M |
| 3 |
Opko Health
OPK
|
+$2.19M |
| 4 |
GeneDx Holdings
WGS
|
+$778K |
| 5 |
Surgery Partners
SGRY
|
+$572K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
+$2.54M |
| 2 |
ProShares UltraPro QQQ
TQQQ
|
+$2.25M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$2.01M |
| 4 |
AGEN
Agenus
AGEN
|
+$1.54M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$1.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.83% |
| 2 | Energy | 0.46% |
| 3 | Technology | 0.41% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CALL
Opko Health
OPK
$1.01B
| $514K | 0.38% |
236,800
-377,500
| -61% | -$591K |
|
|
27
ProShares UltraPro QQQ
TQQQ
$37.2B
| $414K | 0.31% |
140,000
-140,000
| -50% | -$2.25M |
|
|
DMTK
28
DELISTED
DermTech, Inc. Common Stock
DMTK
| $124K | 0.09% |
47,687
-849,762
| -95% | -$2.54M |
|
29
MiNK Therapeutics
INKT
$57.6M
| $106K | 0.08% |
+5,046
| New | +$101K |
|
30
PUT
Cardinal Health
CAH
$56.1B
| – | – |
-130,000
| Closed | -$112K |
|
31
CALL
Centene
CNC
$32.5B
| – | – |
-175,000
| Closed | -$370K |
|
|
DAWN
32
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| – | – |
-185,200
| Closed | -$105K |
|
33
PUT
McKesson
MCK
$103B
| – | – |
-20,000
| Closed | -$184K |
|
34
CALL
Seres Therapeutics
MCRB
$48.2M
| – | – |
-5,000
| Closed | -$95K |
|
|
SWTX
35
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-43,500
| Closed | -$1.12M |
|
|
VTNR
36
CALL
DELISTED
Vertex Energy, Inc
VTNR
| – | – |
-100,400
| Closed | -$245K |
|
|
VLD
37
DELISTED
Velo3D, Inc.
VLD
| – | – |
-2,522
| Closed | -$200K |
|
Similar funds
OBWA
EECFX
PW
PWA
AIMU
HIA
ACA
CWA
Oracle Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Oracle Investment Management held 37 positions worth $136M, up 31% from $103M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Oracle Investment Management deployed $23.8M of net new capital in Q2 2023, opening 10 new positions and adding to 5 existing holdings. Its largest new stake was Blueprint Medicines: 41,377 shares worth $2.62M.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 97% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was DermTech, Inc. Common Stock, an estimated $2.54M trimmed.
- Oracle Investment Management's largest Q2 2023 buy was Blueprint Medicines: 41,377 shares worth $2.62M.
- Oracle Investment Management added most to QuidelOrtho in Q2 2023, an estimated $4.33M increase.
- Oracle Investment Management's biggest Q2 2023 reduction was DermTech, Inc. Common Stock, cutting an estimated $2.54M.
- Oracle Investment Management fully exited SpringWorks Therapeutics in Q2 2023, selling an estimated $1.12M.
- Oracle Investment Management's ten largest holdings make up 79% of its $136M portfolio in Q2 2023.
- Oracle Investment Management opened 10 new positions and closed 8 in Q2 2023.
- Oracle Investment Management's portfolio value rose 31% quarter-over-quarter to $136M.
Based on Oracle Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.